$1.26
0.065%
Last update: Nov 4, 5:06 PM
Anavex Life Sciences Corp
AVXLNASDAQ
The average analyst price target for Anavex Life Sciences is $30, 2281.0% above the current price. Of 4 analysts, 3 rate it Buy and 1 Hold. Targets range from $20 to $46. The latest change came on Nov 19, 2025, when HC Wainwright & Co. lowered its price target on Anavex Life Sciences from $42 to $20 and kept a Buy rating.
Price Target Range — 10 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months
